AbbVie: towards innovative therapies with “Alfons”

On January 15, 2019, Posted by , In News, By , , With Comments Off on AbbVie: towards innovative therapies with “Alfons”

What does the future of research actually look like? Alfons” gives an answer to this question. What sounds like a first name that has gone out of fashion stands for the finest in high technology. “Automated Liquid Formulation Screening” is a real innovation: Using the data generated with this system,…

DKFZ/EMBL: Algorithm identifies multiple gene–environment relationships

On November 30, 2018, Posted by , In News, By , , With Comments Off on DKFZ/EMBL: Algorithm identifies multiple gene–environment relationships

Researchers at the German Cancer Research Center (DKFZ), EMBL’s European Bioinformatics Institute (EMBL-EBI) and the Wellcome Sanger Institute have developed a new computational method that makes it possible to identify the impact of hundreds of environmental factors on genotype–environment interactions. The method will enhance understanding of relationship between genotype and…

HS-Analysis: how softwares can contribute to cancer treatment development

On August 23, 2018, Posted by , In News, By , , With Comments Off on HS-Analysis: how softwares can contribute to cancer treatment development

Finding a cure to any type of cancer is one of the biggest challenge in medicine. HS-Analysis wants to bring the concer research forward with the help of a software. Read about the plans of Sergey Biniaminov (Managing Director of HS Analysis) in the interview with ka-news (in German).

HITS: New computational method for drug discovery

On July 12, 2018, Posted by , In News, By , , With Comments Off on HITS: New computational method for drug discovery

HITS researchers developed tauRAMD, a tool to predict drug-target residence times from short simulations. The method is illustrated on the cover page of July 2018 issue of the Journal of Chemical Theory and Computation, software is freely available. The graphical image used for the cover of the JCTC . Image:…